Abstract

We explored if HIV infection is associated with impaired T-Helper 17 responses against Streptococcus pneumoniae in the lung. We recruited 30 HIV-uninfected healthy controls, 23 asymptomatic HIV-infected adults not on ART, and 40 asymptomatic HIV-infected adults on ART (Median time 3.5yrs), in whom we collected bronchoalveolar lavage fluid. We measured alveolar CD4+ T cell immune responses following stimulation with pneumococcal cell culture supernatant using flow cytometry-based intracellular cytokine staining. We found that the proportion of alveolar CD4+ T cells producing IL-17A following stimulation with pneumococcal cell culture supernatant (CCS) was similar between HIV-uninfected controls and ART-naïve HIV-infected adults (0.10% vs. 0.14%; p=0.9273). In contrast, the proportion and relative absolute counts of CD4+ T cells producing IL-17A in response to pneumococcal CCS were higher in ART-treated HIV-infected adults compared HIV-uninfected controls (0.22% vs. 0.10%, p=0.0166; 5420 vs. 1902 cells/100ml BAL fluid; p=0.0519). The increase in relative absolute numbers of IL-17A-producing alveolar CD4+ T cells in ART-treated individuals was not correlated with the peripheral blood CD4+ T cell count (r=-0.1876, p=0.1785). Alveolar Th17 responses against S. pneumoniae are preserved in HIV-infected adults. This suggests that there are other alternative mechanisms that are altered in HIV-infected individuals that render them more susceptible to pneumococcal pneumonia.

Highlights

  • Invasive pneumococcal disease (IPD), in the form of pneumonia and bacteraemia is a leading cause of mortality worldwide.[1,2] HIV-infected adults are 60 times more likely to suffer IPD than age-matched HIV-negative persons.[3,4,5] Initiation of antiretroviral therapy (ART) has led to a reduction in the incidence of IPD in HIV-infected individuals.[4]

  • We have previously shown that IFN-γ- and TNF-producing alveolar CD4+ T cell responses to Streptococcus pneumoniae are maintained in asymptomatic chronic HIV-infected individuals.[8]

  • We investigated the impact of ART on IL-17A, TNF and IFN-γ-producing alveolar CD4+ T cells, by stimulating bronchoalveolar lavage (BAL) cells obtained from ART-treated HIV-infected adults with pneumococcal cell culture supernatant (CCS) and determining the proportions of the responding cells using flow cytometry-based intracellular cytokine staining

Read more

Summary

Introduction

Invasive pneumococcal disease (IPD), in the form of pneumonia and bacteraemia is a leading cause of mortality worldwide.[1,2] HIV-infected adults are 60 times more likely to suffer IPD than age-matched HIV-negative persons.[3,4,5] Initiation of antiretroviral therapy (ART) has led to a reduction in the incidence of IPD in HIV-infected individuals.[4]. We have previously shown that IFN-γ- and TNF-producing alveolar CD4+ T cell responses to Streptococcus pneumoniae are maintained in asymptomatic chronic HIV-infected individuals.[8] This suggested that the increased risk to pneumococcal pneumonia in these individuals might not be due to depletion of these important CD4+ T cell subsets in the alveoli. IL-17A-producing CD4+ T cells in the lung have been shown to be critical in conferring protection in murine models of pneumococcal lung infection.[9,10] In humans, our data from an experimental pneumococcal nasal carriage model showed that pneumococcal carriage leads to increased frequency of pneumococcal-specific Th17 cells in the lung, and that alveolar macrophages exhibited enhanced killing of opsonised pneumococci upon stimulation with recombinant human IL-17A.11. The link between pneumococcal-specific Th17 immunity and increased risk of pneumococcal pneumonia in HIV-infected individuals has not yet been substantiated

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.